Month: February 2026

Qnity After the Spin: Strong Earnings, Big Move, and a Reminder Why Spinoffs Matter

By |
0 Comment

DuPont’s Qnity Electronics (NYSE: Q) has now been public long enough to stop blaming “spin-off dynamics” for every tick in the stock — and just in time, because the company just delivered a quarter that actually earned the attention. To rewind: DuPont completed the separation of its Qnity Electronics business on November 1, 2025, with DuPont(DD) shareholders receiving… Read More »

Avidity Biosciences Sets Atrium Spinoff Ahead of Novartis Buyout

By |
0 Comment

Avidity Biosciences – the San Diego rare disease biotech being acquired by Novartis for $12 billion – is spinning off its early-stage cardiology unit into a new company called Atrium Therapeutics. In a move that gives Avidity’s shareholders a parting gift as they surrender the rest of the company to Novartis, Avidity’s board designated February 12, 2026 as… Read More »